These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 30863408

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L, Wang SF, Zhao ZL, Yang RY.
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
    Cai Y, Zhou PJ, Tang XD.
    Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway.
    Guo Z, Meng L, Kim O, Wang J, Hart J, He G, Alegre ML, Thistlethwaite JR, Pearson TC, Larsen CP, Newell KA.
    Transplantation; 2001 May 15; 71(9):1351-4. PubMed ID: 11403253
    [Abstract] [Full Text] [Related]

  • 9. Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade.
    Vogel I, Verbinnen B, Van Gool S, Ceuppens JL.
    J Immunol; 2016 Jul 15; 197(2):533-40. PubMed ID: 27288533
    [Abstract] [Full Text] [Related]

  • 10. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N, McAlister JC, Rogers NJ, Tan PH, George AJ, Larkin DF.
    Invest Ophthalmol Vis Sci; 2003 Sep 15; 44(9):3899-905. PubMed ID: 12939307
    [Abstract] [Full Text] [Related]

  • 11. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G, Strom TB, Li XC.
    J Immunol; 2003 Oct 01; 171(7):3878-85. PubMed ID: 14500690
    [Abstract] [Full Text] [Related]

  • 12. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL.
    J Immunol; 2000 Jan 01; 164(1):512-21. PubMed ID: 10605049
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H, Sayegh MH, Najafian N.
    J Immunol; 2005 Jun 01; 174(11):6648-56. PubMed ID: 15905503
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
    Williams MA, Trambley J, Ha J, Adams AB, Durham MM, Rees P, Cowan SR, Pearson TC, Larsen CP.
    J Immunol; 2000 Dec 15; 165(12):6849-57. PubMed ID: 11120808
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
    Xie B, Chen J, Wang F, Lan T, Wang Y, Xia J, Li Z, Xie Q, Huang R, Qi Z.
    Scand J Immunol; 2010 May 15; 71(5):345-52. PubMed ID: 20500685
    [Abstract] [Full Text] [Related]

  • 17. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo.
    Kishimoto K, Dong VM, Issazadeh S, Fedoseyeva EV, Waaga AM, Yamada A, Sho M, Benichou G, Auchincloss H, Grusby MJ, Khoury SJ, Sayegh MH.
    J Clin Invest; 2000 Jul 15; 106(1):63-72. PubMed ID: 10880049
    [Abstract] [Full Text] [Related]

  • 18. New insights in CD28-independent allograft rejection.
    Habicht A, Najafian N, Yagita H, Sayegh MH, Clarkson MR.
    Am J Transplant; 2007 Aug 15; 7(8):1917-26. PubMed ID: 17617854
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo.
    Bingaman AW, Ha J, Durham MM, Waitze SY, Tucker-Burden C, Cowan SR, Pearson TC, Larsen CP.
    Transplantation; 2001 Oct 15; 72(7):1286-92. PubMed ID: 11602857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.